All News #Library
Rare Diseases
Atsena Wins FDA Fast Track For ATSN-201 Gene Therapy
12 Mar 2025 //
GLOBENEWSWIRE
Atsena Begins Ph I/II Gene Therapy Trial For X-Linked Retinoschisis
08 Jan 2025 //
GLOBENEWSWIRE
Atsena Therapeutics Receives Orphan Drug Designation for ATSN-201
17 Sep 2024 //
GLOBENEWSWIRE
Atsena Therapeutics Gets FDA Rare Pediatric Disease Designation For ATSN-201
14 Aug 2024 //
GLOBENEWSWIRE
Atsena Therapeutics Receives Orphan Drug Designation from the FDA
28 Jun 2021 //
GLOBENEWSWIRE

Market Place
Sourcing Support